Engineering Anti-Tumor Monoclonal Antibodies and Fc Receptors to Enhance ADCC by Human NK Cells
Tumor-targeting monoclonal antibodies (mAbs) are the most widely used and characterized immunotherapy for hematologic and solid tumors. The significance of this therapy is their direct and indirect effects on tumor cells, facilitated by the antibody’s antigen-binding fragment (Fab) and fragment crys...
Main Authors: | Kate J. Dixon, Jianming Wu, Bruce Walcheck |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/2/312 |
Similar Items
-
Obinutuzumab-mediated high-affinity ligation of FcγRIIIA/CD16 primes NK cells for IFNγ production
by: Cristina Capuano, et al.
Published: (2017-03-01) -
Deciphering Fc-mediated Antiviral Antibody Functions in Animal Models
by: Alan L. Schmaljohn, et al.
Published: (2019-07-01) -
Multivariate analysis of FcR-mediated NK cell functions identifies unique clustering among humans and rhesus macaques
by: Marina Tuyishime, et al.
Published: (2023-12-01) -
Update on Fc-Mediated Antibody Functions Against HIV-1 Beyond Neutralization
by: Bin Su, et al.
Published: (2019-12-01) -
Increasing the clinical efficacy of NK and antibody-mediated cancer immunotherapy: potential predictors of successful clinical outcome observed in high-risk neuroblastoma
by: Tony A. Koehn, et al.
Published: (2012-05-01)